middle.news
Recce Pharmaceuticals Raises A$4 Million to Advance Licensing and Trials
10:03am on Friday 26th of June, 2026 AEST
•
Healthcare
Read Story
Recce Pharmaceuticals Raises A$4 Million to Advance Licensing and Trials
10:03am on Friday 26th of June, 2026 AEST
Key Points
A$4 million raised via institutional placement at A$0.40 per share
Share Purchase Plan offers up to A$4 million on same terms
Funds target commercial licensing with Middle Eastern pharma partner
Ongoing Phase 3 trials and Investigational New Drug activities funded
Read Story
middle.
Tap to Read
Tap the card to read the full analysis
about
Recce Pharmaceuticals (ASX:RCE)
OPEN ARTICLE